Moderna’s Covid-19 vaccine shows 93% efficacy through 6 months, as company expects to finish application for approval this month
By Naomi Thomas and Jason Hanna, CNN Moderna’s Covid-19 vaccine showed 93% efficacy against symptomatic disease through six months, and the company expects to complete its application for full approval from the US Food and Drug Administration this month, the company said Thursday. The efficacy data came from a final analysis of the vaccine’s Phase
Continue Reading